Medications

Aristada approved for schizophrenia

(HealthDay)—Aristada (aripiprazole lauroxil) extended release injection has been approved by the U.S. Food and Drug Administration to treat the disabling brain disorder schizophrenia, the agency said Tuesday in a news release.

Medications

First generic Abilify approved

(HealthDay)—The first generic versions of the atypical antipsychotic drug Abilify (aripiprazole) have been approved by the U.S. Food and Drug Administration to treat schizophrenia or bipolar disorder.

Diseases, Conditions, Syndromes

Atypical antipsychotics up renal injury risk in seniors

(HealthDay)—Use of atypical antipsychotic drugs is associated with increased risk of acute kidney injury (AKI) in older adults, according to research published in the Aug. 19 issue of the Annals of Internal Medicine.

Psychology & Psychiatry

Australians double their antidepressants

(Medical Xpress)—The use of antidepressants doubled in Australia between 2000 and 2011 and they now account for two out of every three psychotropic medications prescribed, a new study by the University of Sydney reveals.

page 2 from 3